Human Hippocampal Neurogenesis Persists in Aged Adults and Alzheimer’s Disease Patients

Whether hippocampal neurogenesis persists throughout life in the human brain is not fully resolved. Researchers of the Department of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, IL, USA demonstrate in a just published paper on Cell Stem Cell that hippocampal neurogenesis is persistent through the tenth decade of life and is detectable

Read More


Allogeneic stem cell transplantation in non-Hodgkin lymphoma: benefit remains unclear

Meaningful studies are lacking for certain patient groups / Disease-specific registries could help close the data gap The German Institute for Quality and Efficiency in Health Care (IQWiG) has investigated whether patients suffering from non-Hodgkin lymphoma have (better) chances of recovery when stem cells from another person are transplanted. In its final report now presented,

Read More


Millions of Europeans at risk of chronic digestive diseases, new report reveals

Source  United European Gastroenterology Poor nutritional choices, including a high intake of ultra-processed foods and trans-fats, are putting millions of Europeans at an increased risk of a range of chronic digestive diseases, including digestive cancers, wheat related disorders and functional GI disorders, as well as obesity, a new report shows. Nutrition and Chronic Digestive Diseases,

Read More


Exercise and antioxidants: A winning combination for brain health?

An international team of researchers representing several institutions in Japan and the US has published promising findings that may stand to benefit people living with the specter of Alzheimer’s and other neurodegenerative diseases, as well as age-related cognitive decline. In their paper published in PNAS, “Leptin in hippocampus mediates benefits of mild exercise by an antioxidant

Read More


In a controlled Trial for Mild Asthma Budesonide–Formoterol as needed found superior to Albuterol

In double-blind, placebo-controlled trials, budesonide–formoterol used on an as needed basis resulted in a lower risk of severe exacerbation of asthma than as-needed use of a short-acting β2 -agonist (SABA); the risk was similar to that of budesonide maintenance therapy plus as-needed SABA. The availability of data from clinical trials designed to better reflect clinical

Read More